MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from note
payable
$1,650K
Net cash flows
provided by financing...
$337K
Effect of exchange rate
changes on cash
$3K
Canceled cashflow
$1,313K
Net decrease in cash
-$176K
Canceled cashflow
$340K
Inventory
-$827K
Amortization of debt discount
$513K
Stock-based compensation
$497K
Amortization of right of use
assets
$238K
Depreciation and
amortization
$192K
Prepaid expenses and
other
-$166K
Other
$138K
Accounts receivable, net
-$124K
Deferred taxes
-$3K
Repayment of note payable
$1,050K
Repayment of unsecured
debt
$173K
Debt issuance costs
related to note payable
$90K
Net cash flows used
in operating...
-$407K
Canceled cashflow
$2,698K
Net cash flows used
in investing...
-$109K
Accounts payable and
accrued expenses
-$1,342K
Net loss
-$958K
Benefit from reversal of
accrued payroll tax...
-$522K
Operating lease liability
-$245K
Gain on debt
extinguishment
$38K
Purchases of property and
equipment
$109K
Product sales, net
$13,789K
Loss before income
taxes
-$949K
Income tax expense
(benefit)
$9K
Gross profit
$6,752K
Canceled cashflow
$7,037K
Other expense, net
-$479K
Operating loss
-$470K
Canceled cashflow
$6,752K
Benefit from reversal of
accrued payroll taxes
-$522K
Cost of goods sold
$7,037K
Total operating
expenses
$7,222K
Canceled cashflow
$522K
General and
administrative expense
$3,153K
Sales expense
$2,803K
Marketing expense
$1,666K
Research and development
expense
$122K
Back
Back
Cash Flow
source: myfinsight.com
CV Sciences, Inc. (CVSI)
CV Sciences, Inc. (CVSI)